Different response to chronic somatostatin analogues in patients with central hyperthyroidism

Clinical Endocrinology

Volumn 62, Issue 2, 2005, Pages 176-181

  Mannavola, Deborah ^a   Persani, Luca ^a   Vannucchi, Guia ^a   Zanardelli, Maddalena ^a   Fugazzola, Laura ^a   Verga, Uberta ^a   Facchetti, Marco ^b   Beck Peccoz, Paolo ^a,c  

^a UNIVERSITY OF MILAN   (Italy)

^b Ospedale di Romano di Lombardia   (Italy)

^c Institute of Dermatological Sciences   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

LIOTHYRONINE; OCTREOTIDE; SOMATOSTATIN DERIVATIVE; THYROTROPIN; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; DIAGNOSTIC AGENT; THYROXINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DIFFERENTIAL DIAGNOSIS; DRUG EFFECT; FEMALE; FOLLOW UP; FREE LIOTHYRONINE INDEX; HUMAN; HYPERTHYROIDISM; HYPOPHYSIS ADENOMA; MALE; PRIORITY JOURNAL; THYROID HORMONE RESISTANCE; THYROTOXICOSIS; THYROTROPIN RELEASE; ADENOMA; BLOOD; DELAYED RELEASE FORMULATION; HYPOPHYSIS TUMOR; MIDDLE AGED; SECRETION; TREATMENT OUTCOME;

ADENOMA; ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC AGENTS, HORMONAL; DELAYED-ACTION PREPARATIONS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; HYPERTHYROIDISM; MALE; MIDDLE AGED; OCTREOTIDE; PITUITARY NEOPLASMS; THYROTROPIN; THYROXINE; TREATMENT OUTCOME; TRIIODOTHYRONINE;

EID: 13444256594     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2004.02192.x     Document Type: Article

References (32)

1. Refetoff, S., Weiss, R. & Usala, S. (1993) The syndromes of resistance to thyroid hormone. Endocrine Reviews, 14, 348-399.
2. Beck-Peccoz, P., Brucker-Davis, E, Persani, L., Smallridge, R.C. & Weintraub, B.D. (1996) Thyrotropin-secreting pituitary tumours. Endocrine Reviews, 17, 610-638.
3. McDermott, M.T. & Ridgway, E.G. (1998) Central hyperthyioidism. Endocrinology and Metabolism Clinics of North America, 27, 187-203.
4. Chatterjee, V.K.K., Clifton-Bligh, R.J. & Gurnell, M. (1999) Thyroid hormone resistance. In: J.L. Jameson, ed. Contemporary Endocrinology: Hormone Resistance Syndromes. Humana Press, Totowa, NJ, 145-153.
5. Sanno, N., Teramoto, A. & Osamura, R.Y. (2001) Thyrotropin-secreting pituitary adenomas. Clinical and biological heterogeneity and current treatment. Journal of Neuroncology, 54, 179-186.
6. Adams, M., Matthews, C., Colllingwood, T.N., Tone, Y., Beck-Peccoz, P. & Chatterjee, K.K. (1994) Genetic analysis of 29 kindreds with generalized and pituitary resistence to thyroid hormone. Identification of 13 novel mutations in the hormone receptor B gene. Journal of Clinical Investigation, 94, 506-515.
7. Brucker-Davis, F., Skarulis, M.C., Grace, M.B., Benichou, J., Hauser, P., Wiggs, E. & Weintraub, B.D. (1995) Genetic and clinical features of 42 kindreds with resistance to thyroid hormone. The national Institute of Health Prospective Study. Annals of Internal Medicine, 328, 997-583.
8. Mannavola, D. & Beck-Peccoz, P. (2004) Syndromes of resistance to thyroid hormone: clinical aspects. In: P. Beck-Peccoz, ed. Syndromes of Hormone Resistance on the Hypothalamic-Pituitary-Thyroid Axis. Kluwer Academic, Massachusetts, USA.
9. Beck-Peccoz, P. & Persani, L. (1994) Variable biological activity of thyroid-stimulating hormone. European Journal of Endocrinology, 131, 331-340.
10. Reutrakul, S., Sadow, P., Pannain, S., Poholenz, J., Carvalho, G.A., Macchia, P.E., Weiss, R.E. & Refetoff, S. (2000) Search for abnormalities of nuclear corepressors, coactivators and a coregulator in families with resistance to thyroid hormone without mutations in thyroid hormone receptor β or α gene. Journal of Clinical Endocrinology and Metabolism, 85, 3609-3617.
11. Molitch, M.E. & Russel, E.J. (1990) The pituitary 'incidentaloma'. Annals of Internal Medicine, 112, 925-931.
12. Watanabe, K., Kameya, T., Yamauchi, A., Yamamoto, N., Kuwayama, A., Takei, I., Maruyama, H. & Saruta, T. (1993) Thyrotropin-producing adenoma associated with pituitary resistance to thyroid hormone. Journal of Clinical Endocrinology and Metabolism, 76, 1025-1030.
13. Gurnell, M., Rajanayagam, O., Barbar, I., Jones, M.K. & Chatterjee, V.K. (1998) Reversible pituitary enlargement in the syndrome of resistance to thyroid hormone. Thyroid, 8, 679-682.
14. Safer, I.D., Colan, S.D., Fraser, L.M. & Wondisfoid, F.E. (2001) A pituitary tumour in a patient with thyroid hormone resistance: a diagnostic dilemma. Thyroid, 11, 281-291.
15. Beck-Peccoz, P., Mariotti, S., Guillausseau, P.J. et al. (1989) Treatment of hyperthyroidism due to inappropriate secretion of thyrotropin with the Somatostatin analogue SMS 201-995. Journal of Clinical Endocrinology and Metabolism, 68, 208-214.
16. Chanson, P., Weintraub, B.D. & Harris, A.G. (1993) Octreotide therapy for thyroid stimulating-secreting pituitary adenomas. A follow-up of 52 patients. Annals of Internal Medicine, 119, 236-240.
17. Cancel, A., Vuillerment, P., Legrand, A., Catus, F., Thomas, F. & Kuhn, J.M. (1994) Effects of a slow-release formulation of the new somatostatin analogue lanreotide in TSH-secreting pituitary adenomas. Clinical Endocrinology, 40, 421-428.
18. Brucker-Davis, E, Oldfield, E.H., Skarulis, M.C., Doppman, J.L & Weintraub, B.D. (1999) Thyrotropin-secreting pituitary tumours: diagnostic criteria, thyroid hormone sensitivity, and treatment outcome in 25 patients followed at the National Institutes of Health. Journal of Clinical Endocrinology and Metabolism, 84, 476-486.
19. Kuhn, J.M., Arlot, S., Lefebvre, H. et al. (2000) Evaluation of the treatment of thyrotropin-secreting pituitary adenomas with a slow release formulation of the somatostatin analogue lanreotide. Journal of Clinical Endocrinology and Metabolism, 85, 1487-1491.
20. Caron, P., Arlot, S., Bauters, C. et al. (2001) Efficacy of the long-acting octreotide formulation (Ocreotide-LAR) in patients with thyrotropin-secreting pituitary adenomas. Journal of Clinical Endocrinology and Metabolism, 86, 2849-2853.
21. Beck-Peccoz, P. & Persani, L. (2002) Medical management of thyrotropin-secreting pituitary adenomas. Pituitary, 5, 83-88.
22. Williams, G., Kraenzlin, M., Sandier, L., Burrin, J., Law, A., Bloom, S. & Joplin, G.F. (1986) Hyperthyroidism due to non-tumoural inappropriate TSH secretion. Effect of a long-acting somatostatin analogue (SMS 201-995). Acta Endocrinologica (Copenh), 113, 42-46.
23. Lamberts, S.W., van der Lely, A.J. & Hofland, L.J. (2002) New somatostatin analogues: will they fulfil old promises? European Journal of Endocrinology, 146, 701-705.
24. Parrilla, R., Mixson, A.J., McPherson, I.A., McClaskey, J.H. & Weintraub, B.D. (1991) Characterization of seven novel mutations of the c-erbA beta gene in unrelated kindreds with generalised thyroid hormone resistance. Evidence of two 'hot-spot' regions of the ligand binding domain. Journal of Clinical Investigation, 88, 2123-2130.
25. Takeda, K., Weiss, R.E. & Refetoff, S. (1992) Rapid localization of mutations in the thyroid hormone receptor-beta gene by denaturing gradient gel electophoresis in 18 families with thyroid hormone resistance. Journal of Clinical Endocrinology and Metabolism, 74, 712-719.
26. Lancranjan, L, Bruns, C. & Gras, P. (1995) Sandostatin LAR: pharmacokinetics, pharmacodynamics, efficacy and tolerability in acromegalic patients. Metabolism, 44, 18-26.
27. Ezzat, S. & Melmed, S. (1992) Endocrine applications of the somatostatin analogue octreotide (Sandostatin). Metabolism, 41, 34-38.
28. Curry, F.H., Lisboa, P.C., Ortigha-Carvalho, T.M. & Pazos-Moura, C.C. (2000) The somatostatin analogue modulates iodothyronine deiodinase activity and pituitary neuromedin B. Thyroid, 10, 647-652.
29. Magner, J., Klibanski, A., Fein, H. et al. (1992) Ricin and lentil lectin-affinity chromatography reveals oligosaccharide heterogeneity of thyrotropin secreted by 12 human pituitary tumours. Metabolism, 41, 1009-1015.
30. Beck-Peccoz, P., Persani, L. & Faglia, G. (1992) Glycoprotein hormone alpha-subunit in pituitary adenomas. Trends in Endocrinology and Metabolism, 3, 41-45.
31. Francis, T.B., Smallridge, R.C., Kane, J. & Magner, J.A. (1993) Octreotide changes serum thyrotropin (TSH) glycoisomer distribution as assessed by lectin chromatography in a TSH macroadenoma patient. Journal of Clinical Endocrinology and Metabolism, 77, 183-187.
32. Hill, S.A., Falko, J.M., Wilson, C.B. & Hunt, W.E. (1982) Thyrotropin-producing pituitary adenomas. Journal of Neurosurg, 57, 515-519.